How Does a Tumor Get Its Shape? MicroRNAs Act as Morphogens at the Cancer Invasion Front
Open Access
- 9 June 2020
- journal article
- research article
- Published by MDPI AG in Non-Coding RNA
- Vol. 6 (2), 23
- https://doi.org/10.3390/ncrna6020023
Abstract
The generation and organization of the invasion front shape of neoplasms is an intriguing problem. The intimate mechanism is not yet understood, but the prevailing theory is that it represents an example of morphogenesis. Morphogenesis requires the presence of specific molecules, known as morphogens (activators and inhibitors), which can diffuse and elicit dose-dependent responses in their target cells. Due to their ability to modulate most of the coding transcriptome, their well-established role in embryogenesis, and their capacity to rapidly move between neighboring and distant cells, we propose microRNAs as inhibitors that could shape the cancer invasion front. In order to explain the genesis of the tumor border, we use Alan Turing’s reaction diffusion model, refined by Meinhardt and Gierer. This assumes the existence of an activator called a, and an inhibitor called h, which we hypothesize could be a freely moving microRNA. We used the fractal dimension as a measure of tumor border irregularity. We observed that the change in fractal dimension associates with variations in the diffusion coefficient of the activator (Da) or the inhibitor (Dh). We determined that the fractal dimension remains constant (i.e., the irregularity of the tumor border does not change) across a Dh interval, which becomes narrower as Da rises. We therefore conclude that a change in fractal dimension occurs when the balance between Da and Dh is disrupted. Biologically, this could be explained by a faulty distribution of the inhibitor caused by an abnormal density of the intercellular connection network. From a translational perspective, if experimentally confirmed, our observations can be used for a better diagnosis of cancer aggressiveness.Funding Information
- National Institutes of Health (UH3TR00943- 01)
- National Cancer Institute (1R01 CA182905-01, 1R01CA222007-01A1, 1R01GM122775-01)
- U.S. Department of Defense (CA160445P1)
This publication has 41 references indexed in Scilit:
- Neutral Sphingomyelinase 2 (nSMase2)-dependent Exosomal Transfer of Angiogenic MicroRNAs Regulate Cancer Cell MetastasisJournal of Biological Chemistry, 2013
- Distinct AGO1 and AGO2 associated miRNA profiles in human cells and blood plasmaRNA Biology, 2012
- miRNAs and morphogen gradientsCurrent Opinion in Cell Biology, 2012
- MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteinsNature, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Most mammalian mRNAs are conserved targets of microRNAsGenome Research, 2008
- Small Regulatory RNAs May Sharpen Spatial Expression PatternsPLoS Computational Biology, 2007
- Nanotubular Highways for Intercellular Organelle TransportScience, 2004
- HOW IMPORTANT IS TUMOUR SHAPE? QUANTIFICATION OF THE EPITHELIAL-CONNECTIVE TISSUE INTERFACE IN ORAL LESIONS USING LOCAL CONNECTED FRACTAL DIMENSION ANALYSISThe Journal of Pathology, 1996
- Positional information and the spatial pattern of cellular differentiationJournal of Theoretical Biology, 1969